Trends in the Russian pharmaceutical market: results of 2024

In a sense, the Russian pharmaceutical market in 2024 can be compared to a raging ocean. On the one hand, Russian pharmaceutical companies actively developed and registered analogues of foreign medicines, were engaged in the creation of innovative medicines, on the other hand, there was a shortage of saline.

1. New drugs on the Russian market.

Some drugs that appeared on the Russian market in 2024 are shown in the table below.:

It is worth noting that most of the drugs are intended for the treatment of life-threatening diseases, and some of them entered the market in order to prevent shortage in the Russian market. In this regard, the year 2024 can be called truly significant in the development of the pharmaceutical industry.

At the same time, in the fall of 2024, medical institutions, pharmacies and consumers faced a shortage of saline solution – 0.9% isotonic sodium chloride solution, necessary to replenish the volume of fluid in the vessels, for example, with blood loss or intense vomiting.

Russian President Vladimir Putin, responding to a question about the shortage of saline, said: "We have always had enough insulin, saline is generally nonsense. I'll try to keep an eye on it. As for saline solutions, it's not about solutions, but about packages. Two departments — the Ministry of Industry and the Ministry of Health — did not make a timely decision on the prices of this package, and the cost that was offered became unprofitable for manufacturers."

By the end of the year, RNC Pharma analysts had recorded a record increase in the volume of sodium chloride infusion solutions (saline) in circulation. The maximum production rates were shown by Mosfarm and Grotex. Grotex increased its output by 47%.